Nexium and Vigabatrin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nexium (esomeprazole magnesium) and Vigabatrin (vigabatrin). Common drug interactions include pneumonia among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Nexium and Vigabatrin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Nexium?

Nexium has active ingredients of esomeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 245,677 Nexium users. Check the latest studies of Nexium.

What is Vigabatrin?

Vigabatrin has active ingredients of vigabatrin. eHealthMe is studying from 4,046 Vigabatrin users. Check the latest studies of Vigabatrin.



On Jul, 11, 2026

20 people who take Nexium and Vigabatrin together, and have interactions are studied.

Nexium and Vigabatrin drug interactions.

What are the common drug interactions of Nexium and Vigabatrin, by gender? *:

female:

  1. Pneumonia
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Dehydration (dryness resulting from the removal of water)
  4. Dyspepsia (indigestion)
  5. Ear infection
  6. Hypersensitivity
  7. Infection
  8. Injection site mass
  9. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  10. Respiratory rate increased (excess breathing rate/min)

male:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Urinary tract infection
  4. Vomiting
  5. Adverse event
  6. Death
  7. Pneumonia
  8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  9. Hospitalisation
  10. Lung infection

What are the common drug interactions of Nexium and Vigabatrin, by age (0-1 to 60+)? *:

0-1:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Blood pressure increased
  3. Infantile spasms
  4. Lung infection
  5. Pneumonia
  6. Pyrexia (fever)

2-9:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Adverse event
  3. Death
  4. Pneumonia
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Urinary tract infection
  7. Vomiting

10-19:

  1. Hypersensitivity
  2. Infection
  3. Injection site mass
  4. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  5. Pneumonia
  6. Respiratory rate increased (excess breathing rate/min)
  7. Seasonal allergy (allergic condition due to certain season)
  8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  9. Upper respiratory tract infection
  10. Urinary tract infection

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 8 people, 40.00%
  2. Infantile Spasms: 5 people, 25.00%
  3. Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 3 people, 15.00%
  4. Immunodeficiency: 2 people, 10.00%
  5. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 5.00%
  6. Insomnia (sleeplessness): 1 person, 5.00%
  7. Idiopathic Generalised Epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis): 1 person, 5.00%
  8. Hypotonia (low muscle tone): 1 person, 5.00%
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 5.00%
  10. Bronchopulmonary Dysplasia (chronic lung disorder in infants - enlargement of an organ or tissue by the proliferation of cells of an abnormal type): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nexium and Vigabatrin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nexium and Vigabatrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vigabatrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nexium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vigabatrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on esomeprazole magnesium and vigabatrin (the active ingredients of Nexium and Vigabatrin, respectively), and Nexium and Vigabatrin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: